Skip to main content
Premium Trial:

Request an Annual Quote

Score One for Open Access

Publishing company Springer has acquired BioMed Central, the largest open access publisher with more than 180 peer-reviewed journals. Springer's Derk Haank said in a statement, "This acquisition reinforces the fact that we see open access publishing as a sustainable part of STM publishing, and not an ideological crusade."

Over at Open Access News, Peter Suber's already parsing the news, starting with his reasoning that Springer will maintain the open access status of all the BMC journals. He adds that this deal should not be seen "as a sign of BMC's failing health. On the contrary. ... The purchase is a sign of Springer's confidence that BMC will continue its long, steady climb from the red to the black."

 

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.